tiprankstipranks
Trending News
More News >
Ianthus Capital Holdings (OTC) (TSE:IAN)
:IAN

iAnthus Capital Holdings (IAN) AI Stock Analysis

Compare
93 Followers

Top Page

TS

iAnthus Capital Holdings

(OTC:IAN)

Rating:45Neutral
Price Target:
iAnthus Capital Holdings faces significant financial challenges, with persistent net losses and negative equity posing substantial risks. While there is improvement in cash flow, it remains insufficient to cover losses. Technical indicators are neutral, and valuation metrics are unfavorable due to negative earnings. The stock's stability provides some support, but profitability and balance sheet issues are critical concerns.

iAnthus Capital Holdings (IAN) vs. iShares MSCI Canada ETF (EWC)

iAnthus Capital Holdings Business Overview & Revenue Model

Company DescriptioniAnthus Capital Holdings, Inc. is a multi-state operator in the cannabis industry, primarily focused on the cultivation, processing, and distribution of cannabis products in the United States. The company operates under various brand names and provides a wide range of products, including flowers, edibles, and concentrates, catering to both medical and recreational cannabis markets.
How the Company Makes MoneyiAnthus Capital Holdings makes money through the sale of cannabis products across its network of dispensaries and cultivation facilities. The company generates revenue by growing and processing cannabis, which is then sold under its various brands in retail locations. Additionally, iAnthus benefits from wholesale distribution agreements, selling its products to other retailers. Strategic partnerships and acquisitions also play a significant role in expanding its market presence and revenue potential. The company's earnings are influenced by state regulations, consumer demand, and its ability to efficiently manage its supply chain and operational costs.

iAnthus Capital Holdings Financial Statement Overview

Summary
iAnthus Capital Holdings shows signs of improvement in revenue and cash flow generation; however, its profitability and balance sheet remain weak. Persistent net losses, negative equity, and the high level of debt pose significant risks. Continued focus on improving profitability and reducing leverage is essential for sustainable financial health.
Income Statement
45
Neutral
The company has faced inconsistent revenue growth with a recent positive trend, up 5.22% from 2023 to 2024. However, profitability remains a challenge as reflected by the negative EBIT and net income margins. Despite an improvement in EBITDA margin, rising from negative to positive, the net profit margin remains negative, indicating ongoing profitability issues.
Balance Sheet
30
Negative
The balance sheet shows a concerning negative stockholders' equity, indicating potential financial distress. The debt-to-equity ratio is not meaningful due to negative equity. The equity ratio is also negative, reflecting a high level of liabilities relative to assets. This financial structure suggests significant leverage and potential risk.
Cash Flow
50
Neutral
Cash flow analysis shows a positive shift in operating cash flow and free cash flow from 2023 to 2024, indicating improved cash generation. The free cash flow to net income ratio is positive, but the operating cash flow to net income ratio is low due to negative net income. While cash flows are improving, they are still insufficient to cover net losses.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue167.57M159.24M163.21M203.02M151.67M
Gross Profit75.11M63.17M74.43M111.28M86.68M
EBITDA21.22M-13.30M-369.80M7.89M-241.27M
Net Income-7.64M-76.62M-449.39M-76.25M-310.03M
Balance Sheet
Total Assets271.04M277.41M303.47M346.74M357.97M
Cash, Cash Equivalents and Short-Term Investments18.54M13.10M14.34M13.24M11.02M
Total Debt210.46M201.00M183.94M228.54M206.29M
Total Liabilities336.58M339.07M292.48M369.14M307.13M
Stockholders Equity-65.54M-61.67M10.99M-22.40M50.84M
Cash Flow
Free Cash Flow7.03M-3.06M-26.55M-4.25M-27.33M
Operating Cash Flow12.54M3.02M-19.50M16.15M-13.07M
Investing Cash Flow-6.28M-3.63M-4.74M-21.32M-11.49M
Financing Cash Flow-339.00K-618.00K22.06M10.24M1.26M

iAnthus Capital Holdings Risk Analysis

iAnthus Capital Holdings disclosed 65 risk factors in its most recent earnings report. iAnthus Capital Holdings reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

iAnthus Capital Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (46)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$25.31M15.036.18%46.04%
TSDB
63
Neutral
$37.49M2.9820.78%-15.44%
58
Neutral
$31.14M-16.22%16.24%46.47%
51
Neutral
$28.52M-203.40%14.82%64.51%
46
Neutral
C$189.62M-4.26-8.56%3.09%13.57%-1.98%
TSIAN
45
Neutral
C$33.68M4.1761.65%3.15%
41
Neutral
$18.10M-74.75%1.48%-174.61%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:IAN
iAnthus Capital Holdings
0.01
-0.02
-60.00%
TSE:LABS
MediPharm Labs
0.07
>-0.01
-6.67%
TSE:DB
Decibel Cannabis Company
0.07
0.02
40.00%
TSE:AYR.A
Ayr Wellness
0.16
-2.55
-94.26%
TSE:EPIC
1CM Inc
0.22
-0.39
-64.17%
TSE:AVCN
Avicanna
0.26
-0.14
-35.00%

iAnthus Capital Holdings Corporate Events

Business Operations and StrategyFinancial Disclosures
iAnthus Capital Holdings Shows Improved Margins Amid Revenue Decline in Q1 2025
Neutral
May 13, 2025

iAnthus Capital Holdings reported a revenue of $38.1 million for Q1 2025, marking a decline from both the previous quarter and the same period last year. Despite the revenue drop, the company saw an improvement in gross margin and a net income of $5.1 million, indicating a positive shift from a net loss in the previous year, which could signal a strengthening position in the cannabis market.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 22, 2025